Investigation of laryngeal pathology: a review of diagnostic techniques

Parker, Dan; Robin, P. E.

doi:10.1111/j.1365-2273.1989.tb00340.x

Cited by 2 publications

(1 citation statement)

References 92 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pathologies of this anatomical site range from benign conditions such as infections and/or inflammation (i.e., laryngitis), benign nodules and/or polyps, to life-threatening pathologies, the most threatening of which is laryngeal cancer. These malignancies can originate from any part of the larynx, including the vocal cords, epiglottis, arytenoid cartilage and other surrounding tissues [1,2].…”

Section: Introductionmentioning

confidence: 99%

Mortality for Laryngeal Cancer before and during the COVID-19 Pandemic

Nocini,

Lippi,

Mattiuzzi

2024

Preprint

View full text Add to dashboard Cite

(1) Background: The interplay between coronavirus disease 2019 (COVID-19) and laryngeal cancer represents a substantial challenge for both patients and healthcare. To garner information on recent mortality data for laryngeal cancer, including during the COVID-19 pandemic, we analyzed real-world data from the US Centers for Disease Control and Prevention (CDC). (2) Methods: We searched the CDC WONDER on-line database 2018-2022 using with the ICD-10 code for laryngeal cancer (C32; malignant neoplasm of larynx). We also performed a sub-analysis between genders, and across ten-year age groups. Data were analyzed with one-way analysis of variance (ANOVA) and Tukey post-hoc test. (3) Results: The trend of age-adjusted mortality ×100,000 did not change significantly between 2018-2022 (p=0.553). Males had higher age-adjusted mortality rates (M/F ratios between 4.6 and 5.0), but no significant variation was found in both genders (males: p=0.676; females: p=0.596). Although the mortality rate remained unchanged in people aged 35-84 years, the variation reached statistical significance in those aged 85 or older (p=0.004), displaying significant increase in 2021 compared to 2018 (p=0.006) and 2019 (p=0.039). (4) Conclusions: The impact of the COVID-19 pandemic on mortality for laryngeal cancer seemed to be relatively modest in the general US population. Nevertheless, closer attention must be paid to older people, in whom the unfavorable consequences of misdiagnosis or mistreating can be exacerbated.

show abstract

Section: Introductionmentioning

confidence: 99%

Mortality for Laryngeal Cancer before and during the COVID-19 Pandemic

Nocini,

Lippi,

Mattiuzzi

2024

Preprint

View full text Add to dashboard Cite

show abstract

Mortality of Laryngeal Cancer before and during the COVID-19 Pandemic

Nocini,

Lippi,

Mattiuzzi

2024

COVID

View full text Add to dashboard Cite

(1) Background: The interplay between coronavirus disease 2019 (COVID-19) and laryngeal cancer represents a substantial challenge for both patients and healthcare. To garner information on recent mortality data for laryngeal cancer, including during the COVID-19 pandemic, we analyzed real-world data from the US Centers for Disease Control and Prevention (CDC). (2) Methods: We searched the CDC WONDER online database 2018–2022 using the ICD-10 code for laryngeal cancer (C32; malignant neoplasm of the larynx). We also performed a sub-analysis between genders and across ten-year age groups. The data were analyzed with one-way analysis of variance (ANOVA) and Tukey’s post hoc test. (3) Results: The trend of age-adjusted mortality ×100,000 did not change significantly between the years 2018 and 2022 (p = 0.553). Males had higher age-adjusted mortality rates (M/F ratios between 4.6 and 5.0), but no significant variation was found in both genders (males: p = 0.676; females: p = 0.596). Although the mortality rate remained unchanged in people aged 35–84 years, the variation reached statistical significance in those aged 85 or older (p = 0.004), displaying a significant increase in 2021 compared to 2018 (p = 0.006) and 2019 (p = 0.039). (4) Conclusions: The impact of the COVID-19 pandemic on mortality for laryngeal cancer seems to be relatively modest in the general US population. Nevertheless, closer attention must be paid to older people, for whom the unfavorable consequences of misdiagnosis or mistreatment of this and other types of cancers can be exacerbated.

show abstract

Investigation of laryngeal pathology: a review of diagnostic techniques

Cited by 2 publications

References 92 publications

Mortality for Laryngeal Cancer before and during the COVID-19 Pandemic

Mortality for Laryngeal Cancer before and during the COVID-19 Pandemic

Mortality of Laryngeal Cancer before and during the COVID-19 Pandemic

Contact Info

Product

Resources

About